Tag: Acute myeloid leukemia
Trovagene updates on acute myeloid leukemia trial for Onvansertib
Trovagene, a California-based cancer research company, said that it has wrapped up the second dosing cohort of the Onvansertib-decitabine combination, in a phase 1b/2 acute ... Read More
Cantex acute myeloid leukemia drug CX-01gets FDA fast track designation
Cantex Pharmaceuticals, a Florida-based biotech company, has secured the fast track designation for its acute myeloid leukemia drug CX-01 from the US Food and Drug ... Read More
Tolero, AbbVie to explore venetoclax alvocidib combo for AML
Tolero Pharmaceuticals said that its cyclin-dependent kinase 9 (CDK9) inhibitor alvocidib will be combined with AbbVie leukemia drug venetoclax to evaluate their potential in their ... Read More
FDA approves Agios’ Tibsovo for acute myeloid leukemia treatment
Tibsovo (ivosidenib) developed by Agios Pharmaceuticals has been approved by the US Food and Drug Administration (FDA) for acute myeloid leukemia treatment in patients with ... Read More
Ivosidenib FDA approval : Agios blood cancer drug approved for AML
Ivosidenib FDA approval : The US Food and Drug Administration (FDA) has approved Agios Pharmaceuticals’ blood cancer drug TIBSOVO (ivosidenib) for the treatment of acute ... Read More
Cyclacel’s blood cancer drug for elderly patients, sapacitabine fails in phase 3 trial
The blood cancer drug for elderly patients, sapacitabine (CYC682) developed by New Jersey based Cyclacel Pharmaceuticals has failed to meet its objective in a crucial ... Read More